Atlas Trials

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Clinical trial NCT01118949 · COMPLETED

Trial details

NCT number
NCT01118949
Sponsor
UCB BIOSCIENCES, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Epilepsy
Start date
2010-05-01
Primary completion
2011-08-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.